Healthy fats' effect on Alzheimer's to be studied
NEWS IN BRIEF — Posted May 28, 2007
The National Institute on Aging is set to conduct a nationwide clinical trial to determine whether the omega-3 fatty acid DHA, or docosahexaenoic acid, taken over several months can slow the progress of cognitive and functional decline from Alzheimer's disease.
Some studies have suggested that these healthy fats may benefit the brain. "The evidence to date in observational and animal studies on omega-3 fatty acids and Alzheimer's disease warrants further evaluation in a rigorous clinical trial," said NIA Director Richard J. Hodes, MD.
The trial will take place at 51 sites across the country. Researchers are seeking 400 participants age 50 and older who have mild to moderate Alzheimer's disease. More data about the trial is available online (link).
Note: This item originally appeared at http://www.ama-assn.org/amednews/2007/05/28/hlbf0528.htm.